Laura Viviani1, Anna Bossi, Baroukh Maurice Assael. 1. Dipartimento di Medicina del Lavoro Clinica del Lavoro L.Devoto, Sezione di Statistica Medica e Biometria G.A. Maccacaro, Università degli Studi di Milano. Via Venezian 1, 20133 Milano, Italy. laura.viviani@unimi.it
Abstract
BACKGROUND: The existence of gender-related differences since childhood in survival of cystic fibrosis (CF) patients has been recently challenged. METHODS: We evaluated the effect of gender on survival of 2293 CF patients born after 01/01/1988, followed up by 29 CF centres until 31/12/2004 and recorded in the Italian Registry for CF (IRCF). RESULTS: We observed similar annual mortality rates in females (3.59‰) and males (4.00‰), similar survival curves (log-rank test p=0.64) and similar hazards of death (hazard ratio adjusted for presence of symptoms at diagnosis, meconium ileus, F508del mutation and age at diagnosis: 1.29, 95%CI: 0.60; 2.76). However, excess mortality due to CF was higher for females (5.9) than males (5.1). CONCLUSIONS: In our population CF females do not experience higher mortality than males but, due to the disease, they lose the expected survival advantage occurring in the general population at this age. We do not exclude, however, that differences in mortality will establish after adolescence.
BACKGROUND: The existence of gender-related differences since childhood in survival of cystic fibrosis (CF) patients has been recently challenged. METHODS: We evaluated the effect of gender on survival of 2293 CF patients born after 01/01/1988, followed up by 29 CF centres until 31/12/2004 and recorded in the Italian Registry for CF (IRCF). RESULTS: We observed similar annual mortality rates in females (3.59‰) and males (4.00‰), similar survival curves (log-rank test p=0.64) and similar hazards of death (hazard ratio adjusted for presence of symptoms at diagnosis, meconium ileus, F508del mutation and age at diagnosis: 1.29, 95%CI: 0.60; 2.76). However, excess mortality due to CF was higher for females (5.9) than males (5.1). CONCLUSIONS: In our population CF females do not experience higher mortality than males but, due to the disease, they lose the expected survival advantage occurring in the general population at this age. We do not exclude, however, that differences in mortality will establish after adolescence.
Authors: Paul J McKiernan; Stephen G J Smith; Andrew L Durham; Ian M Adcock; Noel G McElvaney; Catherine M Greene Journal: J Innate Immun Date: 2019-07-02 Impact factor: 7.349
Authors: Cayce L Harness-Brumley; Alan C Elliott; Daniel B Rosenbluth; Deepa Raghavan; Raksha Jain Journal: J Womens Health (Larchmt) Date: 2014-12 Impact factor: 2.681
Authors: Don B Sanders; Zhanhai Li; Anita Laxova; Michael J Rock; Hara Levy; Jannette Collins; Claude Ferec; Philip M Farrell Journal: Ann Am Thorac Soc Date: 2014-01
Authors: Ana Villaverde-Hueso; Germán Sánchez-Díaz; Francisco J Molina-Cabrero; Elisa Gallego; Manuel Posada de la Paz; Verónica Alonso-Ferreira Journal: Int J Environ Res Public Health Date: 2019-01-04 Impact factor: 3.390
Authors: Carla P Coutinho; Sandra C Dos Santos; Andreia Madeira; Nuno P Mira; Ana S Moreira; Isabel Sá-Correia Journal: Front Cell Infect Microbiol Date: 2011-12-02 Impact factor: 5.293